Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Abbott Laboratories (NY:ABT)

89.17 +1.26 (+1.43%)
Streaming Delayed Price Updated: 3:48 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
News headline image
Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell ↗
See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
This Dividend ETF May Be the Ultimate Income Investment to Put in Your Portfolio Right Now ↗
The Schwab U.S. Dividend Equity ETF checks off all the key boxes investors are likely going to want from a top dividend investment. 
Via The Motley Fool
Topics ETFs
News headline image
Sell in May and Go Away—Starting With These 3 Stocks ↗
Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call. 
Via MarketBeat
Topics Artificial Intelligence
Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullback ↗
Via Chartmill
ABBOTT LABORATORIES (NYSE:ABT) Posts Mixed Q1 2026 Results, Cuts Guidance After Exact Sciences Acquisition ↗
Via Chartmill
News headline image
What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk ↗
This mortgage REIT generates income by originating and managing commercial real estate loans across the United States. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress ↗
Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends. 
Via The Motley Fool
News headline image
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗
They have combined for 118 years of consecutive dividend increases. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lows ↗
These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market. 
Via The Motley Fool
Topics Economy Stocks
News headline image
Want Reliable Dividend Income in May? These 2 Stocks Deliver ↗
These stocks check off multiple boxes for income investors. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy? ↗
A rare yield, Dividend King status, and a steady healthcare business may be creating one of its most interesting income setups in years. 
Via The Motley Fool
News headline image
1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever ↗
This company, which has raised its dividend for 54 consecutive years, is on sale. 
Via The Motley Fool
News headline image
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? ↗
Via MarketBeat
News headline image
How to Pick a Healthcare Stock That Can Weather Any Market ↗
How does a nearly 3% (and growing) dividend yield sound? 
Via The Motley Fool
Topics Economy World Trade
News headline image
This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio
Abbott Labs is a balance of income and growth. 
Via Barchart.com
News headline image
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom ↗
They offer investors very different value propositions. 
Via The Motley Fool
News headline image
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount ↗
Various concerns weighed on appetite for stocks in recent weeks. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond ↗
These stocks pay juicy dividends but also offer much more. 
Via The Motley Fool
Topics Economy
News headline image
Abbott Stock Crash: Rebound Could Be Coming Fast ↗
Via MarketBeat
News headline image
Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings ↗
Abbott Laboratories (NYSE:ABT) reported upbeat Q1 earnings but lowered its 2026 outlook, including dilution from Exact Sciences acquisition. 
Via Benzinga
TSMC's Chip Heat Extends the Record Run, Then Netflix Drops a Double Surprise After the Bell ↗
Via Chartmill
News headline image
Why Abbott Laboratories Stock Tumbled on Thursday ↗
It essentially met analyst expectations for its inaugural quarter of 2026. 
Via The Motley Fool
Which S&P500 stocks are moving on Thursday? ↗
Via Chartmill
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns. 
Via The Motley Fool
Topics Economy
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Abbott (ABT) Q1 2026 Earnings Call Transcript ↗
Abbott (ABT) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
Abbott Laboratories’s (NYSE:ABT) Q1 CY2026 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) announced better-than-expected revenue in Q1 CY2026, with sales up 7.8% year on year to ... 
Via StockStory
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared... 
Via MarketMinute
Topics Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.